Anti-FITC - 90nm Gold Conjugate
Cytodiagnostics
SKU:AC-90-20-05
Couldn't load pickup availability

Anti-FITC - 90nm Gold Conjugate for gold nanoparticle labelling
Use Anti-FITC - 90nm Gold Conjugate when your workflow needs reliable detection of FITC-labelled probes and fluorescein-tagged analytes in Lateral Flow Assay, Immunoblotting and Electron Microscopy. It helps researchers evaluate target fit, assay readout and control strategy before selecting a related label or antibody format.
Scientific fit
The colloidal gold label provides a permanent, electron-dense and optically visible signal for method development and routine detection workflows. This large-format gold label emphasizes strong particle visibility; scientists should optimize blocking, flow and wash conditions for the sample matrix.
Protocol notes
- Supports Lateral Flow Assay, Immunoblotting and Electron Microscopy workflows where FITC-labelled probe signal needs to be interpreted with appropriate controls.
- Useful for converting FITC-labelled antibodies, peptides or nucleic-acid probes into a detectable immunoassay signal.
- Include matched negative controls and optimize blocking to separate true target-associated signal from nonspecific particle binding.
Reference AC-90-20-05 in protocols, purchasing notes and internal reagent libraries when matching this product to your chosen assay. Use this context to compare related conjugates by target, label family and experimental readout.
- Research Area:
- Bioconjugation & Labeling • Assay Development • Immunology
- Application:
- Lateral Flow Assay • Immunoblotting • Electron Microscopy
- Reactivity:
- FITC
- Host:
- Sheep
- Isotype:
- IgG
- Formulation:
- 1XPBS (pH 7.4), 20% glycerol (v/v), 1% BSA
- Adsorption Max:
- 564nm
- Core Size:
- 90nm
- Shape:
- Spherical
- Material:
- Gold
- Storage Temperature:
- 4°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.